Targeted In Situ Base Editing of Gut Bacteria in Mice Using Engineered Phage Particles
Engineered phage-derived particles can efficiently deliver base editors to modify target genes in gut bacteria colonizing the mouse intestine, enabling investigation of bacterial gene function and potential microbiome-targeted therapies.